Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
AstraZeneca today announced the European Medicines Agency has accepted the Marketing Authorisation Application (MAA) for lesinurad 200mg tablets. Lesinurad is a selective uric acid reabsorption...
-
PEGASUS-TIMI 54 STUDY OF BRILINTA® MEETS PRIMARY ENDPOINT IN BOTH 60MG AND 90MG DOSES Both BRILINTA 60mg and 90mg demonstrate statistically significant reduction in major cardiovascular thrombotic...
-
LYNPARZA™ approved by the US FOOD AND DRUG ADMINISTRATION FOR THE TREATMENT OF ADVANCED OVARIAN CANCER IN PATIENTS WITH GERMLINE BRCA-MUTATIONS AstraZeneca today announced that the US Food and Drug...
-
LYNPARZA™ approved IN THE EUROPEAN UNION as FIRST-IN-CLASS treatment for ADVANCED BRCA-MUTATED OVARIAN CANCER AstraZeneca today announced that the European Commission (EC) has granted Marketing...
-
MOVENTIG® APPROVED IN THE EUROPEAN UNION FOR OPIOID-INDUCED CONSTIPATION First in class treatment approved for adult patients with opioid-induced constipation who have had an inadequate response to...
-
JURY VERDICT FAVOURS ASTRAZENECA IN NEXIUM ANTITRUST LITIGATION AstraZeneca today announced that a jury in the US District Court for the District of Massachusetts returned a verdict in favour of...
-
NEW DRUG APPLICATION FOR IRESSA ACCEPTED BY US FOOD AND DRUG ADMINISTRATION AstraZeneca today announced that the US Food and Drug Administration (FDA) has accepted for filing the New Drug...
-
AMGEN AND ASTRAZENECA ANNOUNCE POSITIVE RESULTS FROM THIRD AND FINAL PIVOTAL PHASE III STUDY OF BRODALUMAB IN PATIENTS WITH MODERATE-TO-SEVERE PLAQUE PSORIASIS Study met all primary endpoints against...
-
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION Publication of Final Terms in relation to the...
-
DUAKLIR® GENUAIR® approved in the EUROPEAN union FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE AstraZeneca today announced that Duaklir® Genuair® (aclidinium bromide/formoterol fumarate 340/12 mcg) has...